ClinicalTrials.govpublic full text
Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma
multiple myeloma, multiple myeloma, mm, plasma cell myeloma, cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 849646
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.